Jamarcus Brider

ORCID: 0000-0003-0742-5899
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Infective Endocarditis Diagnosis and Management
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac electrophysiology and arrhythmias
  • Pain Management and Treatment
  • Central Venous Catheters and Hemodialysis
  • Anesthesia and Pain Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac tumors and thrombi
  • Pericarditis and Cardiac Tamponade
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac Valve Diseases and Treatments
  • Cerebrovascular and Carotid Artery Diseases
  • Click Chemistry and Applications
  • Retinal and Optic Conditions
  • Transplantation: Methods and Outcomes
  • Neurological disorders and treatments
  • ECG Monitoring and Analysis
  • Pulmonary Hypertension Research and Treatments
  • Cardiovascular and Diving-Related Complications
  • Synthesis and biological activity
  • Viral Infections and Immunology Research
  • Iterative Learning Control Systems

Franciscan Health
2021-2024

The Arrhythmia Institute
2023-2024

Medtronic (United States)
2023

NorthShore University HealthSystem
2023

Arkansas State University
2016

10.1016/s0735-1097(23)03924-4 article EN publisher-specific-oa Journal of the American College of Cardiology 2023-03-01

Introduction: Antiarrhythmic selection for progressive and intractable PVCs unresponsive to first second line regimens can prove challenging. Genetic analysis assists by targeting specific genes, such as the SCN5a gene, which encodes alpha subunit of cardiac sodium channel NaV1.5. Mutations are associated with autosomal dominant phenotypes multifocal ectopic Purkinje-related premature Contractions (MEPPCs). Case: A 38 year old female a history syncope moderate left ventricular systolic...

10.1161/circ.148.suppl_1.11661 article EN Circulation 2023-11-07

Inpatient mortality with infective endocarditis (IE) is 15 to 30% long hospitalizations. In complicated IE, antibiotic therapy alone often not sufficient and surgery necessary when bacteremia persists or vegetations are large.

10.1016/j.hrthm.2024.03.1632 article EN other-oa Heart Rhythm 2024-05-01

Background: Leadless cardiac pacemakers (LCP) have evolved as an excellent alternative to transvenous pacemaker (TVPM) for bradycardia therapy with safety and efficacy outcomes. Micra TM was the first commercially available LCP. The device attaches right ventricular myocardium four Nitinol FlexFix™tines. Its inherent design poses problems retrievability. This leads many devices being turned off left behind in ventricle at end of its life. Aveir retrieval catheter recently launched part...

10.1161/circ.150.suppl_1.4115543 article EN Circulation 2024-11-12

Background: Pulmonary vein isolation (PVI) is the cornerstone therapy during catheter ablation of atrial fibrillation (AF) isolation. 30% patients continue to have recurrent AF despite pulmonary (PV) Defining targets for in PV non responder subgroup continues be challenging technological advances. Volta AF-Xplorer™ (VX) an artificial intelligence (AI) system that analyzes intracardiac signals using electrocardiograms recognize regions spatial temporal dispersion and generate sequential maps...

10.1161/circ.150.suppl_1.4144872 article EN Circulation 2024-11-12

10.1016/s0735-1097(23)04136-0 article EN publisher-specific-oa Journal of the American College of Cardiology 2023-03-01

10.1016/s0735-1097(23)01450-x article EN publisher-specific-oa Journal of the American College of Cardiology 2023-03-01

Introduction: COVID-19 redefined workflows in the field of electrophysiology (EP). The geographic paucity experienced clinical mapping support was a crucial issue that limited worldwide adoption complex ablation procedures. Hypothesis: To ascertain feasibility utilizing novel software for remote and all spectrums cardiac procedures geography. Methods: Ablation performed at Metromed International Cardiac Centre (MICC); India were included this early analysis (EFA). All by single EP operator....

10.1161/circ.148.suppl_1.16588 article EN Circulation 2023-11-07

Background: Right heart (RH) infective endocarditis (IE) is a rare but serious complication of transvenous devices (TVD) often requiring system extraction. Surgery necessary for large vegetations or when bacteremia persists despite antibiotics. Objective: To evaluate outcomes patients who underwent transcatheter debulking IE-related RH in the setting device endocarditis. Methods: Patients with TVD and IE were included this analysis. Half debulked using thrombus aspiration system, while other...

10.1161/circ.148.suppl_1.13750 article EN Circulation 2023-11-07

Introduction: Left atrial appendage closure (LAAC) therapy is approved for stroke prevention in nonvalvular fibrillation (AF) patients intolerant long term oral anticoagulation (OAC). Peri-device leak (PDL) the achilles heel to optimal LAAC and increases risk. Here, we describe novel use of a second device large PDL bilobar appendage. Case: A 66-year-old male with history AF recurrent bleeding on OAC Watchman 2.5 implant six years prior, presented our facility repeat ablation. Pre-procedural...

10.1161/circ.146.suppl_1.12297 article EN Circulation 2022-11-08

Introduction: Despite early mitigation efforts, the opioid pandemic in United States has persisted and affected many Americans. A public health emergency was declared regarding prescriptions. Alternative approaches to postoperative pain control after transvenous cardiac device implants (TCDI) adults have not been described. Methods: We report a single center retrospective analysis of 153 consecutive patients that underwent TCDI from January August 2021 with ultrasound guided pectoral nerve...

10.1161/circ.146.suppl_1.11768 article EN Circulation 2022-11-08
Coming Soon ...